How New Method Cuts Costs for AI-Driven Protein Engineering
A data-first revolution in AI-driven protein engineering is slashing lab costs, reshaping biotech economies, and rewriting who wins drug discovery. New structure-aware generative pipelines turn millions of sequences into fewer, higher-value experiments. Investors, pharma and startups: control the data and the loop—or risk being left behind. Act now or watch.